![Janet L. Smart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Janet L. Smart
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Anchor Therapeutics, Inc.
![]() Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Anchor Therapeutics, Inc. designs and develops peptide modulators of G protein-coupled receptors (GPCRs). The firm engages in developing and licensing pepducin technology as a research tool for drug development; and pepducin drug candidates and novel molecules that are intended for targeting GPCR to allosterically modulate GPCR signaling. Its pepducin lipopeptides are designed to allosterically modulate internal cell signaling via specific interactions with intracellular GPCR domains. The company also focuses on developing its pepducin technology for creating new treatment options for regenerative medicine, diabetes, inflammation, and cancer. Anchor Therapeutics was founded by Thomas J. McMurry and Athan Kuliopulos in 2006 and is headquartered in Cambridge, MA.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Janet L. Smart via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
BASF Bioresearch Corp. | President | ||
Harbour BioMed (Shanghai) Co., Ltd.
![]() Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
Velocon Sports Inc | Director/Board Member | ||
EpimAb Biotherapeutics, Inc.
![]() EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | Pharmaceuticals: Major | Director/Board Member | |
Shangbay Capital Management Co. LLC
![]() Shangbay Capital Management Co. LLC Investment ManagersFinance Shangbay Capital Management Co. LLC (Shangbay Capital) is a venture capital firm founded in 2015. The firm is headquartered in Palo Alto, California. | Investment Managers | Consultant / Advisor | |
European Molecular Biology Organization | Corporate Officer/Principal | ||
HBM HOLDINGS LIMITED | Pharmaceuticals: Other | Director/Board Member | |
NEON THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Amherst College | College/University | Undergraduate Degree | |
JOUNCE THERAPEUTICS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
AbbVie Bioresearch Center, Inc.
![]() AbbVie Bioresearch Center, Inc. BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Bioresearch Center, Inc. is a company that provides drug discovery, development sciences, and biologics research services. The company is based in Worcester, MA. | Biotechnology | President | |
Opsonic Therapeutics, Inc. | Director/Board Member | ||
Harbour Antibodies BV
![]() Harbour Antibodies BV Medical/Nursing ServicesHealth Services Harbour Antibodies BV engages in the production of antibodies and VH domains for therapy. The firm develops two types of human immunoglobulin gene transgenic mice such as mice that generate conventional tetrameric antibodies comprising two heavy and two light immunoglobulin chains (H2L2); and alternatively, mice that generate heavy chain only antibodies comprising two immunoglobulin heavy chains with no light chains (HCAbs). The company was founded by Frank Grosveld in 2006 and is headquartered in Rotterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member | |
Third Rock Ventures LLC
![]() Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
Genetics Institute LLC
![]() Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistieken
Internationaal
Verenigde Staten | 14 |
China | 3 |
Duitsland | 2 |
Kaaimaneilanden | 2 |
Nederland | 2 |
Sectoraal
Health Technology | 9 |
Finance | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Health Services | 2 |
Operationeel
Director/Board Member | 10 |
Independent Dir/Board Member | 4 |
President | 2 |
Consultant / Advisor | 2 |
Corporate Officer/Principal | 2 |
Sterkste connecties
Insiders | |
---|---|
Robert Kamen | 19 |
- Beurs
- Insiders
- Janet L. Smart
- Bedrijfsconnecties